S Beare1, W P Steward. Show Affiliations » 1. National Cancer Institute of Canada, Queen's University, Kingston, Ontario, Canada.
Abstract
Entities: Chemical Disease
Mesh: See more » Antineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useDoxorubicin/adverse effectsDoxorubicin/therapeutic useFree RadicalsHumansIron/bloodIron Chelating Agents/therapeutic useMethotrexate/adverse effectsMethotrexate/therapeutic useNeoplasms/bloodNeoplasms/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/bloodPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyTransferrin/analysis
Substances: See more » Antineoplastic AgentsFree RadicalsIron Chelating AgentsTransferrinDoxorubicinIronMethotrexate
Year: 1996 PMID: 8598694 DOI: 10.1016/s0140-6736(96)90530-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321